Um, Joy
Paley, Michael A.
Article History
Received: 13 January 2026
Accepted: 9 February 2026
First Online: 5 March 2026
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: MAP has received consulting fees from UCB, Priovant, Balboa Biopharma, and EpanaBio and holds stock/stock options for Balboa Biopharma and EpanaBio.